Published in

National Academy of Sciences, Proceedings of the National Academy of Sciences, 8(119), 2022

DOI: 10.1073/pnas.2113947119

Links

Tools

Export citation

Search in Google Scholar

Pharmaceutical pollution of the world’s rivers

Journal article published in 2022 by John L. Wilkinson ORCID, Alistair B. A. Boxall ORCID, Dana W. Kolpin ORCID, Kenneth M. Y. Leung ORCID, Racliffe W. S. Lai ORCID, Cristóbal Galbán-Malagón ORCID, Aiko D. Adell ORCID, Julie Mondon ORCID, Marc Metian ORCID, Robert A. Marchant, Alejandra Bouzas-Monroy ORCID, Aida Cuni-Sanchez ORCID, Anja Coors ORCID, Pedro Carriquiriborde, Macarena Rojo ORCID and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Significance Despite growing evidence of the deleterious effects on ecological and human health, little is known regarding the global occurrence of pharmaceuticals in rivers. Studies assessing their occurrence are available for 75 of 196 countries, with most research conducted in North America and Western Europe. This leaves large geographical regions relatively unstudied. Here, we present the findings of a global reconnaissance of pharmaceutical pollution in rivers. The study monitored 1,052 sampling sites along 258 rivers in 104 countries of all continents, thus representing the pharmaceutical fingerprint of 471.4 million people. We show that the presence of these contaminants in surface water poses a threat to environmental and/or human health in more than a quarter of the studied locations globally.